Fact CheckerSign in

NCT06588205Recruiting

Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

Multicenter, Observational, Retrospective-prospective Study Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

Source: ClinicalTrials.gov · Last updated 29 Dec 2025

Brief summary (registry, in English)

This is a observational, retrospective and prospective study designed to assess the potential correlations between MYC alterations, lymphoma mutational landscape and functional immune contextures in Diffuse Large B-cell Lymphoma or High-Grade B-cell Lymphoma

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
2 Sept 2024
Start date
5 May 2025
Primary completion date
Dec 2027
Lead sponsor
Fondazione Italiana Linfomi - ETS
NCT number
NCT06588205

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 5 May 2025 to the primary completion date, Dec 2027
  • 20 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have received palliative treatment

Other

  • Primary lymphomas of the central nervous system, plasmablastic lymphoma, Burkitt's lymphoma, primary mediastinal B lymphoma

Who the study is looking for

  • Diagnosis of nodal and extranodal Diffuse Large B Cell Lymphoma, High Grade B Cell Lymphomas (including low-grade transformed lymphomas; double and triple hit; 11q aberration; not otherwise specified) after 1st January 2019
  • Presence of one MYC translocation or gain of copies (GCN: \> 3 copies in more than 30% of the nuclei) or amplification evaluated by FISH
  • Availability of immunohistochemical analysis of CD10, Bcl6, MUM1, Bcl2, Myc, Ki67
  • Have received curative treatment (e.g. R-CHOP, R DA EPOCH, intensified "Burkitt like" chemotherapies) as first-line therapy
  • Histological material of adequate size and quality to perform histological review with any additional investigations (immunohistochemistry, FISH and other molecular analysis). A FFPE block must be provided for patient enrollment.
  • Age between 18 and 79 years

Age in the registry: 18 years to 79 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (20)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia
Coordinator of this site? Confirm its status
AlessandriaItalyRecruiting
A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia
Coordinator of this site? Confirm its status
AnconaItalyRecruiting
I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia
Coordinator of this site? Confirm its status
BariItalyRecruiting
ASST Spedali Civili - S.C. Ematologia
Coordinator of this site? Confirm its status
BresciaItalyRecruiting
I.R.C.C.S. Istituto di Candiolo - FPO
Coordinator of this site? Confirm its status
CandioloItalyRecruiting
I.R.C.C.S. Istituto Oncologico Veneto - U.O.C. Oncoematologia
Coordinator of this site? Confirm its status
Castelfranco VenetoItalyNot yet recruiting
ARNAS Garibaldi - U.O.C. Ematologia
Coordinator of this site? Confirm its status
CataniaItalyRecruiting
A.S.T. Macerata - U.O.S.D Ematologia
Coordinator of this site? Confirm its status
Civitanova MarcheItalyRecruiting
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia
Coordinator of this site? Confirm its status
FlorenceItalyRecruiting
ASST Grande Ospedale Metropolitano Niguarda - S.C. Ematologia
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Ospedale Maggiore Policlinico Fondazione IRCCS Ca' Granda - S.C. Ematologia
Coordinator of this site? Confirm its status
MilanItalyRecruiting
I.R.C.C.S. Istituto Oncologico Veneto - U.O.C. Oncologia 1
Coordinator of this site? Confirm its status
PadovaItalyNot yet recruiting
A.O.U. di Padova - U.O.C. Ematologia
Coordinator of this site? Confirm its status
PadovaItalyNot yet recruiting
AUSL Modena sede di Sassuolo - UOSD di Oncologia Area Sud
Coordinator of this site? Confirm its status
SassuoloItalyRecruiting
U.O.C. Ematologia - A.O.U. Senese
Coordinator of this site? Confirm its status
SienaItalyNot yet recruiting
A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia U
Coordinator of this site? Confirm its status
TorinoItalyNot yet recruiting
ULSS 2 Ospedale Ca' Foncello - U.O.C. Ematologia
Coordinator of this site? Confirm its status
TrevisoItalyRecruiting
A.O. Cardinale "G. Panico" - U.O.C Ematologia e Trapianto Midollo Osseo
Coordinator of this site? Confirm its status
TricaseItalyRecruiting
A.S.U. Giuliano Isontina - S.C. Ematologia
Coordinator of this site? Confirm its status
TriesteItalyRecruiting
A.O.U.I. di Verona - Ematologia
Coordinator of this site? Confirm its status
VeronaItalyNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.